Position in NVS
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$532,848
+$13,498 QoQ
Shares Held
3,400
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#859
of 1,603 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VIEWPOINT INVESTMENT PARTNERS CORP holds $4,798,146 across 2 Drug Manufacturers - General names. NVS ranks #2 (11.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
16,950 | $4,265,298 | |
| 2 | NVS |
Novartis AG
This page
|
3,400 | $532,848 |
All Filings in NVS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $532,848 | 3,400 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $519,350 | 3,400 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $358,462 | 2,600 | Shares | Sole | 2026-01-29 | |
| No filing history on record for this holder in this stock. | ||||||